Status:
NOT_YET_RECRUITING
A Randomized Controlled Trial Comparing Whole Body Vibration Therapy With Usual Care and Usual Care to Improve Muscle Health in Older Adults
Lead Sponsor:
Changi General Hospital
Collaborating Sponsors:
BMEC Pte Ltd
Conditions:
Aging
Frailty
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study is a randomized controlled trial where participants would be randomly assigned to one of 2 groups. One group would receive Whole body vibration therapy and usual care and the other group on...
Detailed Description
Background: The prevalence of Frailty and Sarcopenia is increasing with increasing proportion of older adults in the population. While screening for frailty and sarcopenia has become more common, frai...
Eligibility Criteria
Inclusion
- Healthy Volunteer or Patients aged 65 and above,
- Clinical frailty Scale (CFS) score of 3-4,
- Independently ambulating without any aid
- willingness and consent to participate in the study and ability to travel to the study-site for the measurements and interventions, and
- participants with no regular exercise habits (defined as less than 150mins/week of moderate intensity aerobic exercise and less than twice a week of strengthening exercises)for past 3 months.
Exclusion
- current active enrolment into any Day Rehab or community exercise program,
- contraindications to WBVT machine usage (see below),
- diagnosis of dementia,
- history of Diabetes Mellitus
- BMI ≤20kg/m2,
- recent hospital admissions within the last 3 months,
- end stage organ failure,
- chronic diseases which are not well managed, for example, poorly controlled hypertension,
- New York Heart Association (NYHA) score II and above for patients with history of heart failure and
- MUST Score ≥1.
- Contraindications to WBVT:
- PRIMARY CONTRAINDICATIONS TO WBVT
- Pregnancy
- Acute thrombosis (acute vascular occlusion)
- Artificial joints in stimulated body regions
- Fresh fractures in stimulated body regions
- Within 3 months post surgery/procedure and/or any fresh wounds and scars in the stimulated body regions
- or if the wound healing is not yet completely finished.
- SECONDARY CONTRAINDICATIONS TO WBVT
- Acute inflammation of the musculoskeletal system, activated arthrosis or
- arthropathy (e.g. acute inflammation and swelling in joints).
- Acute tendinopathies in stimulated body regions (acute tendonitis)
- Acute hernias (tissue ruptures)
- Acute discopathy (acute disc-related back problem)
- Stone disease of the bile ducts and urinary tract
- Rheumatoid Arthritis
- Epilepsy due to secondary risk of injury
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07205133
Start Date
October 1 2025
End Date
February 1 2027
Last Update
October 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.